Brokerage firm Nuvama expects Kilpest India to sustain healthy growth in the molecular diagnostics business, led by product launches, acquisition of new customers, and geographical expansion. The brokerage has a “buy” rating on the stock with a price target of Rs 1,184. This implies an upside potential of 57% from the current levels.
/PRNewswire/ The "DNA Extraction Kit Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com s offering. The center of.
/PRNewswire/ The "DNA Extraction Kit Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com s offering. The center of.
OraSure Collection Device Cleared by FDA for Covid Testing
OraSure said its saliva-based collection device was included in an FDA emergency-use authorization to expand coronavirus testing.
Author: OraSure (
OSUR) - Get Report, the maker of oral tests for HIV and Ebola, received emergency-use authorization from the Food and Drug Administration for its specimen-collection device to be used in a developing PCR test to detect coronavirus.
The Ottawa company s device is part of 3B BlackBio Biotech s covid-19 test. 3B BlackBio, Bhopal, India, provides molecular-testing products and services.
OraSure s Omnigel saliva-collection device was part of an emergency-use authorization the FDA granted to the 3B BlackBio covid test.